For example, recent nanoformulations decorated on the surface with the anti-HER2 antibody trastuzumab and loading doses of doxorubicin or paclitaxel present elevated cellular binding as well as elevated uptake and intracellular distribution in HER2 + BC cells as compared to non-decorated NPs [64,65]. The gene discussed is ERBB2; the disease is breast cancer.